About Us – #PatientVoice #PatientEmpowerment #PatientAdvocacy #PatientCentricity #PatientLeaders

Due to a number of bad experiences with social media, in the earlier days, I developed a fear of being photographed or filmed.  I am also using these new opportunities in the ‘REAL WORLD’ to help  myself, hopefully, overcome these fears to give me more opportunities for advocacy. … Read More About Us – #PatientVoice #PatientEmpowerment #PatientAdvocacy #PatientCentricity #PatientLeaders

www.healtheo360.com | Register for a ‘PATIENT’ community and ‘Tell your story!’ | New treatment information functionality is live for members!

The healtheo360 community includes patients, their caregivers, family members and friends who come to share their personal healing stories so that others may find inspiration and motivation as they go through the journey of living with their condition.… Read More www.healtheo360.com | Register for a ‘PATIENT’ community and ‘Tell your story!’ | New treatment information functionality is live for members!

Barriers to Patient-Centered Research Aired at Harvard Symposium | EMR & HIPAA |  Andy Oram  |  2 July 2018

‘Involving patients in patient care is a surprisingly recent concern. There was a time when doctors made all the decisions, delivering them as if they had come directly from the entrails of an oracular temple. Visitors were severely limited at hospitals, because family members just got in the way of the professional staff. And although the attitude toward engaging patients and their families has softened somewhat in health care, rigid boundaries still exist in research.’ … Read More Barriers to Patient-Centered Research Aired at Harvard Symposium | EMR & HIPAA |  Andy Oram  |  2 July 2018

BioPharma Dive: Marketing | July 18 | AbbVie delays another Humira rival | PhRMA proposes rebate shake-up

Top Marketing News

How molecular biomarkers are transforming cancer treatment

AbbVie goes 3-0 in delaying Humira rivals

Drug lobby aims to shake up how medicines are paid for

Where does J&J’s new drug fit in the crowded HIV market?
5 drugs to watch as biotechs report Q2

FDA seeks to make more drugs available over the counter

Gilenya patent decision gives MS market a reprieve… Read More BioPharma Dive: Marketing | July 18 | AbbVie delays another Humira rival | PhRMA proposes rebate shake-up

Im-patient UPDATE  >>>  By POPULAR DEMAND We’re now going to North America

If you’re from North America 
and have an idea, or suggestion, that you would like to be put forward for consideration towards the Conference agenda or Conference Design, then we would love to hear from you.  Maybe you’d even like to get more involved!

You can let us know by filling out the survey via the following link  :-)… Read More Im-patient UPDATE  >>>  By POPULAR DEMAND We’re now going to North America